# Novartis Gene Therapies, Inc. – FDA Inspection, Feb 8, 2019

Source: https://www.keypedia.com/records/fda_inspections/novartis-gene-therapies-inc/b459a2fc-1008-4989-8b52-22767733d792
Source feed: FDA_Inspections

> FDA inspection 1086650 of Novartis Gene Therapies, Inc., February 08, 2019. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1086650
- Company Name: Novartis Gene Therapies, Inc.
- Inspection Date: 2019-02-08
- Product Type: Biologics
- Center: Biologics
- Office Name: Chicago District Office
- Citation Count: 0

## Related Documents

- [FDA Inspection 1144535 - 2021-06-16](https://www.keypedia.com/records/fda_inspections/novartis-gene-therapies-inc/13259416-d963-4c3e-9e31-3b3d50b8daf5)

## Related Officers

- Issuing Officer
- Issuing Officer
- [FDA Associated Person](https://www.keypedia.com/people/burnell-m-henry/dece4407-3597-4a58-8756-5abf9db43bbc)
- Issuing Officer
- [Company Rep](https://www.keypedia.com/people/wei-wang/943039ac-3917-4d32-9f58-1886c56aecdd)

Company: https://www.keypedia.com/companies/novartis-gene-therapies-inc/58c140f1-7389-4053-a757-b61650a3a86a

Office: https://www.keypedia.com/offices/chicago-district-office/a510300b-0eaf-4a33-90b5-231d95977669